Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial

NCT03816397 is registered in ClinicalTrials.gov with Nisha Acharya as lead sponsor.

NCT NCT03816397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03816397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
Lead sponsor
Nisha Acharya
Phase
Phase 4
Overall status
Completed
Start date
March 15, 2020
Completion date
April 3, 2025
Enrollment
87 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

jia, uveitis